IVD Antibody Market, Global Outlook and Forecast 2022-2028

June 2022 | 78 pages | ID: I291DAF73B5DEN
Market Monitor Global

Abstracts

IVD Antibody

This report contains market size and forecasts of IVD Antibody in global, including the following market information:

Global IVD Antibody Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global IVD Antibody Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five IVD Antibody companies in 2021 (%)

The global IVD Antibody market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

mAb Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of IVD Antibody include BD PharMingen, Abcam, R&D Systems, Cell Signaling Technology, Affymatrix, BioLegend, Santa Cruz Biotechnologies, Beckman Coulter and Roche/Ventana. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the IVD Antibody manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global IVD Antibody Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global IVD Antibody Market Segment Percentages, by Type, 2021 (%)

• mAb
• pAb
• rAbs

Global IVD Antibody Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global IVD Antibody Market Segment Percentages, by Application, 2021 (%)

• RIA
• ELISA
• CLIA
• LFIA
• Other

Global IVD Antibody Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global IVD Antibody Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies IVD Antibody revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies IVD Antibody revenues share in global market, 2021 (%)

Key companies IVD Antibody sales in global market, 2017-2022 (Estimated), (K Units)

Key companies IVD Antibody sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• BD PharMingen
• Abcam
• R&D Systems
• Cell Signaling Technology
• Affymatrix
• BioLegend
• Santa Cruz Biotechnologies
• Beckman Coulter
• Roche/Ventana

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 IVD Antibody Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global IVD Antibody Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL IVD ANTIBODY OVERALL MARKET SIZE

2.1 Global IVD Antibody Market Size: 2021 VS 2028
2.2 Global IVD Antibody Revenue, Prospects & Forecasts: 2017-2028
2.3 Global IVD Antibody Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top IVD Antibody Players in Global Market
3.2 Top Global IVD Antibody Companies Ranked by Revenue
3.3 Global IVD Antibody Revenue by Companies
3.4 Global IVD Antibody Sales by Companies
3.5 Global IVD Antibody Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 IVD Antibody Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers IVD Antibody Product Type
3.8 Tier 1, Tier 2 and Tier 3 IVD Antibody Players in Global Market
  3.8.1 List of Global Tier 1 IVD Antibody Companies
  3.8.2 List of Global Tier 2 and Tier 3 IVD Antibody Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global IVD Antibody Market Size Markets, 2021 & 2028
  4.1.2 mAb
  4.1.3 pAb
  4.1.4 rAbs
4.2 By Type - Global IVD Antibody Revenue & Forecasts
  4.2.1 By Type - Global IVD Antibody Revenue, 2017-2022
  4.2.2 By Type - Global IVD Antibody Revenue, 2023-2028
  4.2.3 By Type - Global IVD Antibody Revenue Market Share, 2017-2028
4.3 By Type - Global IVD Antibody Sales & Forecasts
  4.3.1 By Type - Global IVD Antibody Sales, 2017-2022
  4.3.2 By Type - Global IVD Antibody Sales, 2023-2028
  4.3.3 By Type - Global IVD Antibody Sales Market Share, 2017-2028
4.4 By Type - Global IVD Antibody Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global IVD Antibody Market Size, 2021 & 2028
  5.1.2 RIA
  5.1.3 ELISA
  5.1.4 CLIA
  5.1.5 LFIA
  5.1.6 Other
5.2 By Application - Global IVD Antibody Revenue & Forecasts
  5.2.1 By Application - Global IVD Antibody Revenue, 2017-2022
  5.2.2 By Application - Global IVD Antibody Revenue, 2023-2028
  5.2.3 By Application - Global IVD Antibody Revenue Market Share, 2017-2028
5.3 By Application - Global IVD Antibody Sales & Forecasts
  5.3.1 By Application - Global IVD Antibody Sales, 2017-2022
  5.3.2 By Application - Global IVD Antibody Sales, 2023-2028
  5.3.3 By Application - Global IVD Antibody Sales Market Share, 2017-2028
5.4 By Application - Global IVD Antibody Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global IVD Antibody Market Size, 2021 & 2028
6.2 By Region - Global IVD Antibody Revenue & Forecasts
  6.2.1 By Region - Global IVD Antibody Revenue, 2017-2022
  6.2.2 By Region - Global IVD Antibody Revenue, 2023-2028
  6.2.3 By Region - Global IVD Antibody Revenue Market Share, 2017-2028
6.3 By Region - Global IVD Antibody Sales & Forecasts
  6.3.1 By Region - Global IVD Antibody Sales, 2017-2022
  6.3.2 By Region - Global IVD Antibody Sales, 2023-2028
  6.3.3 By Region - Global IVD Antibody Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America IVD Antibody Revenue, 2017-2028
  6.4.2 By Country - North America IVD Antibody Sales, 2017-2028
  6.4.3 US IVD Antibody Market Size, 2017-2028
  6.4.4 Canada IVD Antibody Market Size, 2017-2028
  6.4.5 Mexico IVD Antibody Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe IVD Antibody Revenue, 2017-2028
  6.5.2 By Country - Europe IVD Antibody Sales, 2017-2028
  6.5.3 Germany IVD Antibody Market Size, 2017-2028
  6.5.4 France IVD Antibody Market Size, 2017-2028
  6.5.5 U.K. IVD Antibody Market Size, 2017-2028
  6.5.6 Italy IVD Antibody Market Size, 2017-2028
  6.5.7 Russia IVD Antibody Market Size, 2017-2028
  6.5.8 Nordic Countries IVD Antibody Market Size, 2017-2028
  6.5.9 Benelux IVD Antibody Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia IVD Antibody Revenue, 2017-2028
  6.6.2 By Region - Asia IVD Antibody Sales, 2017-2028
  6.6.3 China IVD Antibody Market Size, 2017-2028
  6.6.4 Japan IVD Antibody Market Size, 2017-2028
  6.6.5 South Korea IVD Antibody Market Size, 2017-2028
  6.6.6 Southeast Asia IVD Antibody Market Size, 2017-2028
  6.6.7 India IVD Antibody Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America IVD Antibody Revenue, 2017-2028
  6.7.2 By Country - South America IVD Antibody Sales, 2017-2028
  6.7.3 Brazil IVD Antibody Market Size, 2017-2028
  6.7.4 Argentina IVD Antibody Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa IVD Antibody Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa IVD Antibody Sales, 2017-2028
  6.8.3 Turkey IVD Antibody Market Size, 2017-2028
  6.8.4 Israel IVD Antibody Market Size, 2017-2028
  6.8.5 Saudi Arabia IVD Antibody Market Size, 2017-2028
  6.8.6 UAE IVD Antibody Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 BD PharMingen
  7.1.1 BD PharMingen Corporate Summary
  7.1.2 BD PharMingen Business Overview
  7.1.3 BD PharMingen IVD Antibody Major Product Offerings
  7.1.4 BD PharMingen IVD Antibody Sales and Revenue in Global (2017-2022)
  7.1.5 BD PharMingen Key News
7.2 Abcam
  7.2.1 Abcam Corporate Summary
  7.2.2 Abcam Business Overview
  7.2.3 Abcam IVD Antibody Major Product Offerings
  7.2.4 Abcam IVD Antibody Sales and Revenue in Global (2017-2022)
  7.2.5 Abcam Key News
7.3 R&D Systems
  7.3.1 R&D Systems Corporate Summary
  7.3.2 R&D Systems Business Overview
  7.3.3 R&D Systems IVD Antibody Major Product Offerings
  7.3.4 R&D Systems IVD Antibody Sales and Revenue in Global (2017-2022)
  7.3.5 R&D Systems Key News
7.4 Cell Signaling Technology
  7.4.1 Cell Signaling Technology Corporate Summary
  7.4.2 Cell Signaling Technology Business Overview
  7.4.3 Cell Signaling Technology IVD Antibody Major Product Offerings
  7.4.4 Cell Signaling Technology IVD Antibody Sales and Revenue in Global (2017-2022)
  7.4.5 Cell Signaling Technology Key News
7.5 Affymatrix
  7.5.1 Affymatrix Corporate Summary
  7.5.2 Affymatrix Business Overview
  7.5.3 Affymatrix IVD Antibody Major Product Offerings
  7.5.4 Affymatrix IVD Antibody Sales and Revenue in Global (2017-2022)
  7.5.5 Affymatrix Key News
7.6 BioLegend
  7.6.1 BioLegend Corporate Summary
  7.6.2 BioLegend Business Overview
  7.6.3 BioLegend IVD Antibody Major Product Offerings
  7.6.4 BioLegend IVD Antibody Sales and Revenue in Global (2017-2022)
  7.6.5 BioLegend Key News
7.7 Santa Cruz Biotechnologies
  7.7.1 Santa Cruz Biotechnologies Corporate Summary
  7.7.2 Santa Cruz Biotechnologies Business Overview
  7.7.3 Santa Cruz Biotechnologies IVD Antibody Major Product Offerings
  7.7.4 Santa Cruz Biotechnologies IVD Antibody Sales and Revenue in Global (2017-2022)
  7.7.5 Santa Cruz Biotechnologies Key News
7.8 Beckman Coulter
  7.8.1 Beckman Coulter Corporate Summary
  7.8.2 Beckman Coulter Business Overview
  7.8.3 Beckman Coulter IVD Antibody Major Product Offerings
  7.8.4 Beckman Coulter IVD Antibody Sales and Revenue in Global (2017-2022)
  7.8.5 Beckman Coulter Key News
7.9 Roche/Ventana
  7.9.1 Roche/Ventana Corporate Summary
  7.9.2 Roche/Ventana Business Overview
  7.9.3 Roche/Ventana IVD Antibody Major Product Offerings
  7.9.4 Roche/Ventana IVD Antibody Sales and Revenue in Global (2017-2022)
  7.9.5 Roche/Ventana Key News

8 GLOBAL IVD ANTIBODY PRODUCTION CAPACITY, ANALYSIS

8.1 Global IVD Antibody Production Capacity, 2017-2028
8.2 IVD Antibody Production Capacity of Key Manufacturers in Global Market
8.3 Global IVD Antibody Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 IVD ANTIBODY SUPPLY CHAIN ANALYSIS

10.1 IVD Antibody Industry Value Chain
10.2 IVD Antibody Upstream Market
10.3 IVD Antibody Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 IVD Antibody Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of IVD Antibody in Global Market
Table 2. Top IVD Antibody Players in Global Market, Ranking by Revenue (2021)
Table 3. Global IVD Antibody Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global IVD Antibody Revenue Share by Companies, 2017-2022
Table 5. Global IVD Antibody Sales by Companies, (K Units), 2017-2022
Table 6. Global IVD Antibody Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers IVD Antibody Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers IVD Antibody Product Type
Table 9. List of Global Tier 1 IVD Antibody Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 IVD Antibody Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global IVD Antibody Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global IVD Antibody Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global IVD Antibody Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global IVD Antibody Sales (K Units), 2017-2022
Table 15. By Type - Global IVD Antibody Sales (K Units), 2023-2028
Table 16. By Application – Global IVD Antibody Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global IVD Antibody Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global IVD Antibody Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global IVD Antibody Sales (K Units), 2017-2022
Table 20. By Application - Global IVD Antibody Sales (K Units), 2023-2028
Table 21. By Region – Global IVD Antibody Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global IVD Antibody Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global IVD Antibody Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global IVD Antibody Sales (K Units), 2017-2022
Table 25. By Region - Global IVD Antibody Sales (K Units), 2023-2028
Table 26. By Country - North America IVD Antibody Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America IVD Antibody Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America IVD Antibody Sales, (K Units), 2017-2022
Table 29. By Country - North America IVD Antibody Sales, (K Units), 2023-2028
Table 30. By Country - Europe IVD Antibody Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe IVD Antibody Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe IVD Antibody Sales, (K Units), 2017-2022
Table 33. By Country - Europe IVD Antibody Sales, (K Units), 2023-2028
Table 34. By Region - Asia IVD Antibody Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia IVD Antibody Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia IVD Antibody Sales, (K Units), 2017-2022
Table 37. By Region - Asia IVD Antibody Sales, (K Units), 2023-2028
Table 38. By Country - South America IVD Antibody Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America IVD Antibody Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America IVD Antibody Sales, (K Units), 2017-2022
Table 41. By Country - South America IVD Antibody Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa IVD Antibody Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa IVD Antibody Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa IVD Antibody Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa IVD Antibody Sales, (K Units), 2023-2028
Table 46. BD PharMingen Corporate Summary
Table 47. BD PharMingen IVD Antibody Product Offerings
Table 48. BD PharMingen IVD Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Abcam Corporate Summary
Table 50. Abcam IVD Antibody Product Offerings
Table 51. Abcam IVD Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. R&D Systems Corporate Summary
Table 53. R&D Systems IVD Antibody Product Offerings
Table 54. R&D Systems IVD Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Cell Signaling Technology Corporate Summary
Table 56. Cell Signaling Technology IVD Antibody Product Offerings
Table 57. Cell Signaling Technology IVD Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Affymatrix Corporate Summary
Table 59. Affymatrix IVD Antibody Product Offerings
Table 60. Affymatrix IVD Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. BioLegend Corporate Summary
Table 62. BioLegend IVD Antibody Product Offerings
Table 63. BioLegend IVD Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Santa Cruz Biotechnologies Corporate Summary
Table 65. Santa Cruz Biotechnologies IVD Antibody Product Offerings
Table 66. Santa Cruz Biotechnologies IVD Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Beckman Coulter Corporate Summary
Table 68. Beckman Coulter IVD Antibody Product Offerings
Table 69. Beckman Coulter IVD Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Roche/Ventana Corporate Summary
Table 71. Roche/Ventana IVD Antibody Product Offerings
Table 72. Roche/Ventana IVD Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. IVD Antibody Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 74. Global IVD Antibody Capacity Market Share of Key Manufacturers, 2020-2022
Table 75. Global IVD Antibody Production by Region, 2017-2022 (K Units)
Table 76. Global IVD Antibody Production by Region, 2023-2028 (K Units)
Table 77. IVD Antibody Market Opportunities & Trends in Global Market
Table 78. IVD Antibody Market Drivers in Global Market
Table 79. IVD Antibody Market Restraints in Global Market
Table 80. IVD Antibody Raw Materials
Table 81. IVD Antibody Raw Materials Suppliers in Global Market
Table 82. Typical IVD Antibody Downstream
Table 83. IVD Antibody Downstream Clients in Global Market
Table 84. IVD Antibody Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. IVD Antibody Segment by Type
Figure 2. IVD Antibody Segment by Application
Figure 3. Global IVD Antibody Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global IVD Antibody Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global IVD Antibody Revenue, 2017-2028 (US$, Mn)
Figure 7. IVD Antibody Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by IVD Antibody Revenue in 2021
Figure 9. By Type - Global IVD Antibody Sales Market Share, 2017-2028
Figure 10. By Type - Global IVD Antibody Revenue Market Share, 2017-2028
Figure 11. By Type - Global IVD Antibody Price (US$/Unit), 2017-2028
Figure 12. By Application - Global IVD Antibody Sales Market Share, 2017-2028
Figure 13. By Application - Global IVD Antibody Revenue Market Share, 2017-2028
Figure 14. By Application - Global IVD Antibody Price (US$/Unit), 2017-2028
Figure 15. By Region - Global IVD Antibody Sales Market Share, 2017-2028
Figure 16. By Region - Global IVD Antibody Revenue Market Share, 2017-2028
Figure 17. By Country - North America IVD Antibody Revenue Market Share, 2017-2028
Figure 18. By Country - North America IVD Antibody Sales Market Share, 2017-2028
Figure 19. US IVD Antibody Revenue, (US$, Mn), 2017-2028
Figure 20. Canada IVD Antibody Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico IVD Antibody Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe IVD Antibody Revenue Market Share, 2017-2028
Figure 23. By Country - Europe IVD Antibody Sales Market Share, 2017-2028
Figure 24. Germany IVD Antibody Revenue, (US$, Mn), 2017-2028
Figure 25. France IVD Antibody Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. IVD Antibody Revenue, (US$, Mn), 2017-2028
Figure 27. Italy IVD Antibody Revenue, (US$, Mn), 2017-2028
Figure 28. Russia IVD Antibody Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries IVD Antibody Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux IVD Antibody Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia IVD Antibody Revenue Market Share, 2017-2028
Figure 32. By Region - Asia IVD Antibody Sales Market Share, 2017-2028
Figure 33. China IVD Antibody Revenue, (US$, Mn), 2017-2028
Figure 34. Japan IVD Antibody Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea IVD Antibody Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia IVD Antibody Revenue, (US$, Mn), 2017-2028
Figure 37. India IVD Antibody Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America IVD Antibody Revenue Market Share, 2017-2028
Figure 39. By Country - South America IVD Antibody Sales Market Share, 2017-2028
Figure 40. Brazil IVD Antibody Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina IVD Antibody Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa IVD Antibody Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa IVD Antibody Sales Market Share, 2017-2028
Figure 44. Turkey IVD Antibody Revenue, (US$, Mn), 2017-2028
Figure 45. Israel IVD Antibody Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia IVD Antibody Revenue, (US$, Mn), 2017-2028
Figure 47. UAE IVD Antibody Revenue, (US$, Mn), 2017-2028
Figure 48. Global IVD Antibody Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production IVD Antibody by Region, 2021 VS 2028
Figure 50. IVD Antibody Industry Value Chain
Figure 51. Marketing Channels